Co-Pay Tactic by Benefit Managers Credited with Cutting Prescription Drug Prices

By and | June 6, 2018

  • June 6, 2018 at 1:44 pm
    Phillip says:
    Like or Dislike:
    Thumb up 1
    Thumb down 0

    This affects the person taking the medicine more than the drug companies. The health plans are only interested in saving money and does not care about the patient who needs the medicine but now can’t afford it and most the time, there is no alternative.

  • June 6, 2018 at 1:49 pm
    Cut the Bias says:
    Like or Dislike:
    Thumb up 0
    Thumb down 1

    Excellent work on this effort by these insurers! Who wants to bet the Trump Administration takes credit for this? I set the over under at 4:00 am EST tomorrow.

    While we are at it, O/U on exclamation points, misplaced quotes and capitalization? :P

    • June 6, 2018 at 9:51 pm
      PolarBeaRepeal says:
      Like or Dislike:
      Thumb up 2
      Thumb down 0

      If you read and understood the article, you’d realize the reason is the enabling of increased competition among pharma companies that forced the implementation of the co-pay accumulator programs that limit subsidies to consumers. Without the changes implemented to increase competition, the US health plans woudn’t be ‘forced’ to use co-pay accumulators.

Add a Comment

Your email address will not be published. Required fields are marked *